PUBLISHER: Grand View Research | PRODUCT CODE: 1097015
PUBLISHER: Grand View Research | PRODUCT CODE: 1097015
Australia Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End-use (Medical Use, Recreational Use, Industrial Use), And Segment Forecasts, 2022 - 2030
Australia Legal Cannabis Market Growth & Trends:
Australia legal cannabis market size is expected to reach USD 540.6 million by 2030 and is expected to expand at a CAGR of 30.1% over the forecast period, according to a new report by Grand View Research, Inc. Increasing cannabis legalization, growing patient population, increasing government support, and the presence of local and foreign players in the country are all contributing to the country's rise. Furthermore, the increase in medical marijuana output as a result of increasing demands in the pharmaceutical sector is boosting overall growth.
Based on the source type, the hemp segment dominated the market in Australia and accounted for the highest revenue share of 83.2% in 2021. The increased usage of hemp-based products for different medical and industrial reasons is credited with the market's growth. The rising frequency of epilepsy and other sleep disorders is assisting product uptake, resulting in favorable growth. The marijuana segment, on the other hand, is expected to grow at the fastest rate during the projection period, owing to increased legalization of these products for medicinal and adult use, as well as a rising consumer shift toward obtaining the product through legal channels.
CBD, among the derivatives, accounted for the largest revenue share in 2021. Post legalization in 2021, products containing CBD products have been readily available over the counter and their demand is growing exponentially. Many companies have started introducing new products in the market for several indications. Other category recorded the fastest growth for the forecast period and is also a result of the high influx of products in the market, containing trace amounts of flavonoids, terpenes, and minor cannabinoids which have been used for multiple indications. These factors had a combined positive effect on the market growth.
Based on the end-use type, the industrial application accounted for the highest revenue share of 81% in 2021. The food and beverage, automotive, personal care, construction, and textile industries are all seeing increased demand for hemp fiber and oil, which is helping the market grow. The medical application segment, on the other hand, is predicted to develop at the quickest rate during the forecast period, owing to increased awareness of the health advantages of cannabis products for a variety of medicinal applications, such as anxiety, and chronic pain, sleep disorders, and inflammation.
COVID-19 pandemic caused major shut-downs across all trade imports or export of goods. However, Australia being a local producer of cannabis saw a major spike in its usage for recreational purposes, legal cannabis showed a huge dip in revenues, but has picked up since the restrictions have eased and trade has resumed. Post legalization of cannabis products for OTC sale across various distribution channels, the market is expected to grow manifold.
Australia Legal Cannabis Market Report Highlights:
- The legal cannabis market in Australia is anticipated to grow exponentially by 2030, owing to the cannabis legalization, a growing patient population, more government assistance, and the presence of local and foreign players are all factors to consider
- The increased usage of hemp-based products for different medical and industrial reasons contributed to the growth of the segment in 2021
- CBD products are in high demand due to their multifarious benefits in indications including epileptic seizure, nausea, and arthritic pain
- Industrial applications of hemp fibers and oil are in high demand for a variety of applications, including construction, automotive, personal care, food and beverage, and textiles contributing to the dominance of this segment in 2021
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation
- 1.2 Research Methodology
- 1.2.1 Information Procurement
- 1.3 Information or Data Analysis
- 1.4 Market Formulation & Validation
- 1.4.1 Country Market: CAGR Calculation
- 1.5 Research Methodology
- 1.6 Country Based Segment Share Calculation
- 1.7 List of Secondary Sources
- 1.8 List of Primary Sources
Chapter 2 Executive Summary
- 2.1 Market Summary
- 2.2 Segment Summary
- 2.3 Competitive Analysis
Chapter 3 Australia Legal Cannabis Market: Variables, Trends & Scope
- 3.1 Penetration & Growth Prospects Mapping
- 3.2 Australia Legal Cannabis: Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Rising Patient Population
- 3.2.1.2 Growing Legalization Of Cannabis-Based CBD Products
- 3.2.1.3 Entry Of International Players
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 Stringent Regulations
- 3.2.2.2 Illicit Cannabis Trade
- 3.2.3 Industry Challenge
- 3.2.3.1 Lower market access to cannabis due to absence of legalization programs, leading to smuggling
- 3.2.3.2 Incomplete evidence regarding the effectiveness of medical marijuana
- 3.2.1 Market Driver Analysis
- 3.3 Regulatory Scenario
- 3.3.1 Australia
- 3.3.1.1 Overview
- 3.3.1.2 Cultivation
- 3.3.1.3 Regulatory Bodies Involved
- 3.3.1.4 Import/Export Scenario
- 3.3.1 Australia
- 3.4 Industry Analysis - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
- 3.4.1 Political And Legal Landscape
- 3.4.2 Economic And Social Landscape
- 3.4.3 Technology Landscape
- 3.5 Industry Analysis - Porter's Analysis
- 3.5.1 Threat Of New Entrants - Moderate
- 3.5.2 Bargaining Power Of Buyers - Low
- 3.5.3 Bargaining Power Of Suppliers-Moderate
- 3.5.4 Threat Of Substitutes-Moderate
- 3.5.5 Competitive Rivalry-High
- 3.6 Opportunity Analysis
- 3.7 Value Chain Analysis
- 3.7.1 Raw Material Trends
- 3.7.1.1 Market Price Evolution Of Biomass Commodity Cost (To Processor)
- 3.7.1.2 Manufacturing Trends
- 3.7.1 Raw Material Trends
- 3.8 Australia Legal Cannabis User Pool
- 3.8.1 Estimated Number Of Cannabis Users In Australia From 2016 To 2030
Chapter 4 Australia Legal Cannabis Market: Source Type Estimates & Trend Analysis
- 4.1 Australia Legal Cannabis Market: Source Type Movement Analysis
- 4.1.1 Australia Legal Cannabis Market: Source Type Movement Analysis (2021 & 2030)
- 4.1.2 Hemp
- 4.1.2.1 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.1.2.2 Hemp CBD
- 4.1.2.2.1 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.1.2.3 Supplements
- 4.1.2.3.1 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.1.2.4 Industrial Hemp
- 4.1.2.4.1 Industrial hemp market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.1.3 Marijuana
- 4.1.3.1 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.1.3.2 Flower
- 4.1.3.2.1 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
- 4.1.3.3 Oil & Tinctures
- 4.1.3.3.1 Oil & tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
Chapter 5 Australia Legal Cannabis Market: Derivatives Estimates & Trend Analysis
- 5.1 Australia Legal Cannabis Market: Derivatives Movement Analysis
- 5.1.1 CBD
- 5.1.1.1 CBD market estimates and forecasts, 2016 - 200 (USD Million)
- 5.1.2 THC
- 5.1.2.1 THC market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.1.3 Others
- 5.1.3.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
- 5.1.1 CBD
Chapter 6 Australia Legal Cannabis Market: End-Use Estimates & Trend Analysis
- 6.1 Australia Legal Cannabis Market: End-Use Movement Analysis
- 6.1.1 Medical Use
- 6.1.1.1 Medical use market estimates and forecasts, 2016 - 200 (USD Million)
- 6.1.1.2 Chronic Pain
- 6.1.1.2.1 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.3 Anxiety and Depression
- 6.1.1.3.1 Anxiety and depression market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.4 Cancer
- 6.1.1.4.1 Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.5 Arthritis
- 6.1.1.5.1 Arthritis market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.6 Diabetes
- 6.1.1.6.1 Diabetes market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.7 Glaucoma
- 6.1.1.7.1 Glaucoma market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.8 Migraines
- 6.1.1.8.1 Migraines market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.9 Epilepsy
- 6.1.1.9.1 Epilepsy market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.10 Multiple Sclerosis
- 6.1.1.10.1 Multiple sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.11 AIDS
- 6.1.1.11.1 AIDS market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.12 Amyotrophic Lateral Sclerosis
- 6.1.1.12.1 Amyotrophic Lateral Sclerosis market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.13 Alzheimer's
- 6.1.1.13.1 Alzheimer's market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.14 Post Traumatic Stress Disorder
- 6.1.1.14.1 Post Traumatic Stress Disorder market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.15 Parkinson's
- 6.1.1.15.1 Parkinson's market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.16 Tourette's
- 6.1.1.16.1 Tourette's market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1.17 Others
- 6.1.1.17.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.2 Industrial Use
- 6.1.2.1 Industrial use market estimates and forecasts, 2016 - 2030 (USD Million)
- 6.1.1 Medical Use
Chapter 7 Competitive Landscape
- 7.1 Company Profiles: ASX Listed Cannabis Companies
- 7.1.1 AusCann Group Holdings Ltd
- 7.1.1.1 Company overview
- 7.1.1.2 Financial performance
- 7.1.1.3 Product benchmarking
- 7.1.1.4 Strategic initiatives
- 7.1.2 Cann Group Limited
- 7.1.2.1 Company overview
- 7.1.2.2 Product benchmarking
- 7.1.2.3 Financial performance
- 7.1.2.4 Strategic initiatives
- 7.1.3 Bod Australia
- 7.1.3.1 Company overview
- 7.1.3.2 Financial performance
- 7.1.3.3 Product benchmarking
- 7.1.3.4 Strategic initiatives
- 7.1.4 Zelira Therapeutics
- 7.1.4.1 Company overview
- 7.1.4.2 Product benchmarking
- 7.1.4.3 Strategic initiatives
- 7.1.5 Althea Group
- 7.1.5.1 Company overview
- 7.1.5.2 Financial performance
- 7.1.5.3 Product benchmarking
- 7.1.5.4 Strategic initiatives
- 7.1.6 EPSILON
- 7.1.7.1 Company overview
- 7.1.7.2 Financial performance
- 7.1.7.3 Product benchmarking
- 7.1.7.4 Strategic initiatives
- 7.1.7 MCG Pharma
- 7.1.7.1 Company overview
- 7.1.7.2 Financial performance
- 7.1.7.3 Product benchmarking
- 7.1.7.4 Strategic initiatives
- 7.1.8 ECOFIBRE
- 7.1.8.1 Company overview
- 7.1.8.2 Financial performance
- 7.1.8.3 Product benchmarking
- 7.1.8.4 Strategic initiatives
- 7.1.1 AusCann Group Holdings Ltd
List of Tables
- TABLE 1 List of secondary data sources
- TABLE 2 List of primary sources
- TABLE 3 Estimated number of cannabis users, 2016 - 2030
- TABLE 4 Australia legal cannabis market, by product type, 2016 - 2030 (USD Million)
- TABLE 5 Australia marijuana market, by product, 2016 - 2030 (USD Million)
- TABLE 6 Australia hemp market, by product, 2016 - 2028 (USD Million)
- TABLE 7 Australia legal cannabis market, by end-use, 2016 - 2030 (USD Million)
- TABLE 8 Australia legal cannabis end-use market, by medical application, 2016 - 2030 (USD Million)
List of Figures
- FIG. 1 Market segmentation
- FIG. 2 Market research process
- FIG. 3 Information procurement
- FIG. 4 Primary research pattern
- FIG. 5 Market research approaches
- FIG. 6 Value chain-based sizing & forecasting
- FIG. 7 QFD modeling for market share assessment
- FIG. 8 Market formulation & validation
- FIG. 9 Australia legal cannabis market snapshot, 2021 (USD Million)
- FIG. 10 Penetration & growth prospects mapping
- FIG. 11 Australia legal cannabis market driver impact
- FIG. 12 Australia legal cannabis market restraint impact
- FIG. 13 Opportunity analysis
- FIG. 14 Australia legal cannabis market, source type outlook: Key takeaways
- FIG. 15 Australia legal cannabis market: Source type movement analysis (2021 & 2030) (USD Million)
- FIG. 16 Hemp market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 17 Hemp CBD market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 18 Supplements market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 19 Industrial hemp market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 20 Marijuana market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 21 Flower market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 22 Oil & tinctures market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 23 Australia legal cannabis market, application outlook: Key takeaways
- FIG. 24 Australia legal cannabis market: Application movement analysis (2021 & 2030)
- FIG. 25 Medical use market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 26 Chronic pain market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 27 Anxiety market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 28 Inflammation market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 29 Sleep Disorders market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 30 Others market estimates and forecasts, 2016 - 2030 (USD Million)
- FIG. 31 Industrial use market estimates and forecasts, 2016 - 2030 (USD Million)
